C

Cuorips Inc
TSE:4894

Watchlist Manager
Cuorips Inc
TSE:4894
Watchlist
Price: 4 740 JPY 0.42% Market Closed
Market Cap: 38.1B JPY
Have any thoughts about
Cuorips Inc?
Write Note

Cuorips Inc
Selling, General & Administrative

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Cuorips Inc
Selling, General & Administrative Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Selling, General & Administrative CAGR 3Y CAGR 5Y CAGR 10Y
C
Cuorips Inc
TSE:4894
Selling, General & Administrative
-ÂĄ387.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
GNI Group Ltd
TSE:2160
Selling, General & Administrative
-ÂĄ16.6B
CAGR 3-Years
-32%
CAGR 5-Years
-34%
CAGR 10-Years
-35%
PeptiDream Inc
TSE:4587
Selling, General & Administrative
-ÂĄ7.7B
CAGR 3-Years
-56%
CAGR 5-Years
-30%
CAGR 10-Years
-38%
Takara Bio Inc
TSE:4974
Selling, General & Administrative
-ÂĄ16.4B
CAGR 3-Years
-7%
CAGR 5-Years
-9%
CAGR 10-Years
-8%
Pharma Foods International Co Ltd
TSE:2929
Selling, General & Administrative
-ÂĄ41.4B
CAGR 3-Years
-7%
CAGR 5-Years
-38%
CAGR 10-Years
-47%
S
StemRIM Inc
TSE:4599
Selling, General & Administrative
-ÂĄ622.1m
CAGR 3-Years
-13%
CAGR 5-Years
-27%
CAGR 10-Years
N/A
No Stocks Found

Cuorips Inc
Glance View

Market Cap
38B JPY
Industry
Biotechnology

Cuorips Inc is a Japan-based company mainly engaged in the development and commercialization of regenerative medical products and contract development and manufacturing organization (CDMO) business. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 46 full-time employees. The company went IPO on 2023-06-27. The main product of the Company is human iPS cell-derived cardiomyocyte sheets. The firm provides regenerative medical products for the heart and other areas through in-house research, joint research with universities and other research institutions and major pharmaceutical companies. The firm operates CDMO business using CLiC-1, a commercial cell culture and processing facility with an integrated laboratory based on the Company's original design concept.

Intrinsic Value
234.89 JPY
Overvaluation 95%
Intrinsic Value
Price
C

See Also

What is Cuorips Inc's Selling, General & Administrative?
Selling, General & Administrative
-387.1m JPY

Based on the financial report for Mar 31, 2024, Cuorips Inc's Selling, General & Administrative amounts to -387.1m JPY.

What is Cuorips Inc's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 1Y
-28%

Over the last year, the Selling, General & Administrative growth was -28%.

Back to Top